Extended therapeutic window of a novel peptide inhibitor of TRPM2 channels following focal cerebral ischemia

These data demonstrate the development of a new peptide inhibitor of TRPM2 channels that provides protection from ischemic stroke in young adult and aged male animals with a clinically relevant therapeutic window.